Access to capital, evolving business models, and sustaining innovation were all hot topics that emerged at the 8th LSX World Congress last month in London. The conference, which runs parallel sessions on biotech, healthtech, and medtech, was an opportunity for leaders from across the industry, as well as venture capitalists and financial advisors, to examine ways the industry is moving forward.

A team from Oliver Wyman’s Health and Life Sciences practice was there to engage with peers and lead panel discussions. Below are a few themes we identified from the meeting:

Please click here for the remainder of the post at Oliver Wyman.